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Abstract
Objective—To examine preventive care visit patterns among commercially insured adolescents 
during 2003–2010. In 2005–2007, the Advisory Committee on Immunization Practices (ACIP) 
recommended 3 vaccines targeted at adolescents. We also investigate the relationship between 
preventive care visits and immunization.
Study design—Data were drawn from the MarketScan database. Adolescents aged 11–21 
continuously enrolled in the same insurance plan during the calendar year were included. We 
calculated the annual proportion of adolescents with at least 1 preventive and 1 vaccination-related 
visit. Longitudinal analyses were conducted by following the 1992 birth cohort for 8 consecutive 
years.
Results—The proportion of adolescents making at least 1 preventive visit increased from 24.6%–
41.1% during 2003–2010. The rate of vaccination-related visits increased from 12.9%–26.3%. The 
magnitude of the increase in preventive and vaccination-related visits was greater during the years 
in which ACIP issued recommendations. The rates of preventive and vaccination-related visits 
were considerably higher among female and early adolescents and adolescents in managed care 
plans. Longitudinal analyses indicated that only 2.4% of adolescents had an annual preventive visit 
during the 8 years.
Conclusions—Yearly improvements in preventive care visits by adolescents were substantial. 
ACIP recommendations may be associated with this improvement. However, ongoing efforts are 
needed to improve the use and delivery of preventive care services.
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Preventive care is of particular importance during adolescence as this is the period during 
which healthy habits are developed and risky behaviors are likely to start. Healthcare 
professionals and government officials have published clinical guidelines to address the 
importance of preventive care.1–3 For example, Bright Futures: Guidelines for Health 
Supervision of Infants, Children, and Adolescents3 recommends that adolescents receive an 
annual preventive care visit. Although considerable efforts have been devoted to increasing 
the use of preventive services, studies have documented that the annual proportion of 
adolescents seeking preventive care is low.4–9
An important component of preventive services is immunization. Over the past decade, 3 
vaccines targeted at adolescents aged 11 and 12 have been recommended by the Advisory 
Committee on Immunization Practices (ACIP): meningococcal conjugate vaccine was 
recommended in 2005,10 the tetanus and diphtheria toxoids and acellular pertussis vaccine 
was recommended in 2006,11 and human papillomavirus vaccine (HPV) was recommended 
for use in females in 2007.12 The coverage of these newly recommended vaccines is not 
optimal.13 A main barrier identified in the literature is the lack of routine preventive care 
visits among adolescents.14
Studies have examined preventive visit patterns among adolescents. These studies, however, 
are limited in reporting an overall visit rate or visit rates by subgroups4–7 (changes in 
preventive visit patterns over time are not available) and in using cross-sectional data5,6 
(they could not identify whether changes in visit patterns were due to changes in the 
composition of the study population or to changes in visit patterns by individuals). This 
study adds to the current literature by providing in-depth investigation of the time trend in 
preventive care visits by adolescents. We also conduct longitudinal analyses of preventive 
visit patterns by individual enrollees.
Methods
The study uses the Commercial Claims and Encounters database portion of the MarketScan 
Databases for the years 2003–2010. The Commercial Claims and Encounters data track 
insurance claims from providers using a nationwide sample of employees and dependents 
covered by large self-insured employers and regional health plans. The dataset expands 
dramatically over the years and contains a large proportion of the US commercially insured 
population, ranging from ~8 million individuals in 2003 (~2.6% of the US population) to 45 
million in 2010 (~14.7% of the US population).
Our analyses included adolescents aged 11–21 years during at least 1 of the study years. We 
focused on those who were continuously enrolled in health insurance plans during each 
calendar year. Adolescents were divided into 3 age groups based on the Bright Futures 
guidelines, early adolescence (11–14 years old), middle adolescence (15–17 years old), and 
late adolescence (18–21 years old), to explore age differences in preventive care visits.
This study was reviewed by the Human Subjects Coordinator at the Centers for Disease 
Control and Prevention. As an analysis of secondary data without identifiers, this study did 
not require institutional review board review.
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Based on the Healthcare Effectiveness Data and Information Set (HEDIS),15 we used the 
International Classification of Diseases-9th Revision codes associated with routine medical 
examinations to define preventive care visits (ie, V20.2, V70.0, V70.3, V70.5, V70.6, V70.8, 
and V70.9). Outpatient records with the Current Procedural Terminology codes between 
99381 and 99397 (ie, comprehensive preventive care) were also defined as preventive care 
visits. Our data indicated that comprehensive preventive care was provided in over 80% of 
the preventive care visits. Outpatient visits with International Classification of Diseases-9th 
Revision codes or Current Procedural Terminology codes associated with vaccine 
administration were classified as vaccination-related visits. Note that preventive care and 
vaccination-related visits are not mutually exclusive.
We considered 7 types of health care providers/agencies: pediatricians, family physicians, 
internists, obstetricians and gynecologists, specialists/subspecialists, non-physician 
professionals, and health care facilities or agencies.
Preventive care visit rate was measured by calculating an annual proportion of adolescents 
who had at least 1 preventive care visit. We compared these annual proportions particularly 
among 3 time periods: 2003–2004 (pre-recommendation), 2005–2007 (transition), and 
2008–2010 (post-recommendation). The same approach was used to study the pattern of 
vaccination-related visits. Rates of preventive care and vaccination-related visits were also 
examined by subgroups. To assess changes in visit patterns by individual enrollees, we 
follow the 1992 birth cohort for 8 consecutive years.
Including preventive care provided by specialists/subspecialists may be subject to coding 
errors. Thus, a sensitivity analysis was performed by excluding preventive visits to 
specialists/subspecialists (ie, coded as outpatient visits, not preventive visits).
Results
A total of 4 732 297 adolescents were included, representing 11 933 132 outpatient visits 
during the 8 years. The size of the study population increased from 924 381 to 1 983 226 
during 2003–2010 (Table I). In each year, about 51% were males and 49% were females, 
and approximately 37%, 30%, and 33% were in their early, middle, and late adolescence, 
respectively. Most of our study population resided in the south and north central regions 
(61%) and in metropolitan statistical areas (MSAs) (over 80%). Preferred provider 
organization was the most prevalent health plan among adolescents.
Preventive Care Visits
During 2003–2010, the proportion of adolescents making at least 1 preventive visit increased 
from 24.6% to 41.1% (Table II). Although the time trend in preventive visits generally 
increased, the magnitude of the increase was greater during transition years compared with 
pre- and post-recommendation years.
Rates of preventive care visits within each subgroup were significantly different at the 1% 
level. The trends, however, were similar to the overall trend. Compared with their 
counterparts, the rate of preventive care visit was significantly higher among females and 
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adolescents living in the northeast region, in MSAs, and in managed care insurance plans. 
Examining preventive visit patterns by age group and sex, the proportion of preventive care 
visits was higher among early adolescents than middle and late adolescents (Figure). The 
age difference, however, was noticeably smaller for females, especially during the pre-
recommendation period.
Preventive Care Visits by Provider Type
Preventive care visits made by early adolescents were to pediatricians (61.1%). The number 
dropped to 20.4% for late adolescents. Visits to family physicians rose with age for males 
(35.8% for late adolescents) and visits to obstetricians and gynecologists increased with age 
for females (32.5% for late adolescents); 11.3% of preventive care visits made by 
adolescents of all ages were to specialists/subspecialists; preventive visits to other provider 
types accounted for 8.6% of all preventive visits.
The rate of preventive care provided by pediatricians increased over time, from 35.7% in 
2003 to 50.0% in 2010. Most of the increase was due to older adolescents (15–21 years) 
increasing their visit to pediatricians over time.
Vaccination-Related Visits
The proportion of adolescents making at least 1 annual vaccination-related visit increased 
from12.9%–26.3% during 2003–2010. Visit rates were higher during transition years (an 
average of 39.5%) compared with pre- and post-recommendation years. Early adolescents 
and adolescents in the northeast region, in MSAs, and in managed care plans had a higher 
vaccination-related visit rate compared with their counterparts. The sex difference in 
vaccination-related visits was small during pre-recommendation year; it became statistically 
significant at the 1% level since 2005 with a higher rate for females. Between 2006 and 
2007, the visit rate of females rose dramatically in all age groups.
Preventive Care Visits vs Vaccination-Related Visits
Between 2003 and 2010, the proportion of adolescents who received a vaccine during a 
preventive visit increased by 45.9% and 78.7% for males and females, respectively. Most of 
this increase occurred during the transition period. This suggested that the proportion of 
vaccines delivered during a preventive visit increased rapidly since ACIP issued 
recommendations. There was a decrease starting in 2008, which may be a reflection of older 
adolescents not needing vaccines during their preventive visits since they were vaccinated 
earlier.
Among adolescents who made a vaccination-related visit, the proportion of adolescents who 
also received preventive services diverged between sexes since 2006. This may reflect the 
large number of females receiving HPV as recommended by ACIP in 2007.
Longitudinal Analysis
We constructed an 8-year longitudinal data by restricting our study population to the 1992 
birth cohort (11 years old at the end of 2003). In doing so, we were able to track changes in 
preventive visit patterns by individual enrollees across their adolescence (from 11 to 18 
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years old between 2003 and 2010). Twenty-one thousand four hundred fifty-one (27.2%) 
adolescents of the 1992 birth cohort met the sample inclusion criteria and were included in 
the analysis.
During the 8 years, 18.2% of males and 13.8% of females had not made any preventive care 
visits. The mean number of preventive visits was 3.6 and 3.9 for males and females, 
respectively (Table III). Only 2.4% of adolescents made at least 1 preventive care visit each 
year throughout this 8-year period and the numbers were very similar between sexes. The 
proportion of adolescents who had not made any vaccination-related visit during the same 
time period was 25.2% for males and 21.9% for females.
The time trend in preventive care visits was very similar to the trend using the full sample. 
Between 2003 and 2010, there was a large increase in the proportion of adolescents with at 
least 1 preventive visit (from 27.7%–37.3%, P < .01). The proportion increased from 28.5%–
32.0% for males and from 26.7%–42.7% for females and the increase was greater during 
transition years for both sexes.
Sensitivity Analysis
Results were very similar if we excluded preventive care provided by specialists/
subspecialists. The rate of preventive visits by adolescents increased from20.7%–
37.2%during 2003–2010.
Discussion
Yearly improvements in preventive care visits for adolescents were substantial between 2003 
and 2010. The rates, however, were far from optimal in relation to the recommendations by 
Bright Futures. Several studies have documented barriers to access and to provision of 
preventive care services, including low income, not having continuous insurance coverage, 
lack of confidentiality, limitations on choices of providers, physician attitudes and beliefs, 
and lack of provider training.4,16–21 Although expansions in Medicaid and State Children’s 
Health Insurance Programhave improved adolescents’ access to health care services,22 and 
several intervention strategies have been proven to be effective in addressing these barriers,
23–25
 our result suggests that ongoing efforts are needed to further promote the use and 
delivery of preventive care.
Our findings revealed that preventive visit rate was considerably lower among middle and 
late adolescents. Although the goals of vaccination are to vaccinate as early as possible, 
adolescents would be best served if they had preventive visits when they were initiating risky 
behaviors (middle adolescence). Thus, efforts to increase preventive visits among all ages 
during adolescence are important.
Several findings suggested that ACIP recommendations were associated with the increase in 
adolescents’ vaccination-related visits. First, the average growth rate of vaccination-related 
visits was higher during the years in which ACIP issued recommendations. Second, most 
vaccines recommended were targeted at early adolescents, which was consistent with the 
finding that visit rate was higher among early adolescents. Finally, HPV was recommended 
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in 2007. As a result, females in all age groups were more likely to make a vaccination-
related visit after 2006. Our data showed a decrease in vaccination-related visits among 
middle and late adolescent females during 2009–2010. This may result from a cohort effect 
because older females may have received all recommended vaccines at an earlier age, 
thereby reducing their need for vaccination-related visits.
Similar trends in preventive and vaccination-related visits are consistent with the notion that 
immunization could act as a hook to increase healthcare visits, which may provide an 
opportunity for the delivery of other types of preventive care services.26
Our longitudinal analyses indicated that only 2.4% of adolescents made an annual preventive 
care visit and 16.1% had not made any preventive visit during the same time period. These 
results reinforce our earlier conclusion that significant efforts have to be made to increase 
the use of preventive services among adolescents.
Our findings should be interpreted in light of some limitations. First, our data show that 
preventive care visits increased rapidly during the years that ACIP issued recommendations. 
The causal relationship, however, is not statistically tested and other factors may play a vital 
role in the improvement in preventive visits. For example, the fact that the proportion of 
adolescents making at least 1 preventive care visit is a HE-DIS measure27 and the 
publication of several clinical guidelines1,3,28 may have led to increases in preventive care 
visits. Moreover, changes in insurance coverage, in reimbursements for preventive care and 
immunization services, or in regional or school requirements for immunization and regular 
preventive care visits may also play a role. However, preventive care visits for adolescents 
have been adopted as a HEDIS measure since 199629 and the clinical guidelines were 
published before our study years. Moreover, we are not aware of any significant change in 
insurance coverage, reimbursement policy, or in regional or school requirements during 
transition years. Therefore, these factors are not likely to play a major role in explaining the 
rapid increase in preventive care visits by adolescents during the transition years.
Other limitations come from the MarketScan data. First, the data were generated from 
insurance claims and thus included in-plan outpatient visits. We may therefore underestimate 
preventive care or vaccination-related visits because of the inability to track non-recorded 
health care visits by adolescents. On the other hand, our definition of preventive care visits 
includes both routine medical examinations and comprehensive preventive services, which 
might overestimate the rate of preventive care visits. However, over 80% of the preventive 
visit records in our data indicated that comprehensive preventive care was provided and 
these services were coded by physicians. Therefore, we believe that our number represents 
an acceptably accurate proportion of commercially insured adolescents making an annual 
preventive visit. Second, the number of our study population increased dramatically during 
our study period, which, to some extent, may contribute to changes in the rates of preventive 
and vaccination-related visit. However, the results from the longitudinal analysis confirmed 
the increasing time trend in preventive visits and also suggested that preventive care is 
underutilized by adolescents. Third, our study population included adolescents continuously 
enrolled in a private insurance plan, which limited generalizability to the US population. The 
low preventive care visit rate among commercially insured adolescents, however, raises 
Tsai et al. Page 6
J Pediatr. Author manuscript; available in PMC 2018 January 23.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
serious concerns as this group is likely to represent a better scenario compared with the 
uninsured population.
Our study adds to the current literature by presenting time trends in preventive care visits by 
commercially insured adolescents over an 8-year period. Although ACIP recommendations 
and a variety of policies and efforts might have been associated with the substantial 
improvement in adolescents seeking preventive care, the results indicate that innovative 
interventions are necessary to promote further increases in the uptake of preventive services 
by adolescents.
Glossary
ACIP Advisory Committee on Immunization Practices
HEDIS Healthcare Effectiveness Data and Information Set
HPV Human papillomavirus vaccine
MSA Metropolitan statistical area
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Figure. 
Percentage of adolescents having at least 1 preventive care visit, 2003–2010 by sex and age 
group.
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Table III
Longitudinal analysis on the percentage of adolescents having at least 1 preventive care visit, 2003–2010 
MarketScan database
Preventive care visits
Having at least 1 visit Male Female
For 1 y 15.4 15.4
For 2 y 14.9 16.2
For 3 y 14.1 15.1
For 4 y 13.0 13.5
For 5 y 9.9 10.9
For 6 y 7.8 7.7
For 7 y 4.5 5.0
For 8 y 2.3 2.5
No visit during the 8 y 18.2 13.8
Mean number of visits 3.6 3.9
Adolescents included were those born in 1992 and enrolled in the same insurance plan for 8 years.
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